Research Funding
Funding for research is a high priority for Hemophilia of Georgia.
Gene Therapy to Cure Hemophilia
Since 2012, Hemophilia of Georgia has funded gene therapy research at two institutions: The Aflac Cancer and Blood Disorders Center at Emory University, Atlanta and St. Jude Children’s Research Hospital in Memphis, Tennessee. Our contributions of over $8 million are to develop a cure for hemophilia (factor VIII, factor IX, and factor VII deficiencies).
Hemophilia Clinical Scientist Development Grants
Since 2003, Hemophilia of Georgia has directly funded physician researchers to conduct translational research on hemophilia and its complications. Each grant is for seventy-five thousand dollars ($75,000.00) per year, renewable for up to five years, and an additional seven thousand five hundred dollars ($7,500.00) for indirect costs. The grant requires an 80%-time commitment to bleeding disorders-related research.
Hemophilia of Georgia hopes to help create the next generation of hemophilia researchers through this program. This funding will allow a physician who has completed research training to advance to the status of an independent investigator. Our goal is for the achievements of these scientists to improve the lives of people with bleeding disorders.
Eligibility
Applicants must have an MD degree and have a minimum of three years of research experience. Because the purpose of this grant is to further the development of beginning researchers, well-established bleeding disorders scientists (including recipients of NIH R01 or NSF grants) are not eligible to apply. Applicants must be US citizens, have permanent resident status (hold an I-551), or be non-citizen nationals.
Applicants must be sponsored by a non-federal public or private non-profit institution conducting health-related research within the US and its possessions. A full-time faculty appointment is required throughout the award period.
If you need copies of the grant policies, rules, and application form or have questions about the application process, please email the Grants Management Coordinator at dpbernard@hog.org.
Past Research Grantees.
Funding for the American Thrombosis and Hemostasis Network
HoG was a catalyst for the creation of the American Thrombosis and Hemostasis Network (ATHN), a non-profit organization founded to advance and improve the care of individuals affected by bleeding and thrombotic disorders. ATHN’s mission is to provide stewardship of a secure national database adherent to all privacy guidelines, supporting clinical outcomes analysis, research, advocacy, and public health reporting in the hemostasis and thrombosis community.
Hemophilia of Georgia continues to fund projects that utilize the ATHN database. We fund ATHN 5 – “Comparison of Hepatitis C Virus (HCV) Treatment Regimens in Patients with Hemophilia and Other Bleeding Disorders” with the goal of eradicating hepatitis C from the bleeding disorder community. We also regularly fund ATHN DREAM awards. The DREAM Award (Dataset Research Engagement and ATHN Mentorship Award) is a mentored research grant given collaboratively by the Hemostasis and Thrombosis Research Society (HTRS) and ATHN. Designed to enhance the care of patients with bleeding and clotting disorders, the award provides up to $100,000 over 24 months for young investigators at ATHN-affiliated HTCs, who work under the guidance of experienced mentors.
We have made contributions to ATHN 8 – “U.S. Cohort Study of Previously Untreated Patients (PUPs) with Congenital Hemophilia” – this study provides a platform for ongoing clinical research studies to improve the outcomes of this vulnerable population.
We have also contributed to the ATHN WAPPS-Hemo (Web-based Application for the Population Pharmacokinetic Service – Hemophilia) Integration and Patient Reported Outcomes (PRO) Application Projects, and most recently, to the ATHN Transcends Research Study.
Judith Graham Pool Postdoctoral Research Fellowships
Hemophilia of Georgia has been a long-time funder of the JGP Research Fellowship program of the National Bleeding Disorders Foundation. Not only do we fully fund fellows, but we have endowed the program to ensure that basic research into bleeding disorders continues.
Funding an Active Research Community in Georgia
Hemophilia of Georgia provides funding for research by the Infectious Disease/Hemophilia Program at Emory Midtown and the Hemophilia Treatment Centers at Augusta University, Emory University/Children’s Healthcare of Atlanta (CHOA), and Memorial Health University Medical Center at Savannah. Their research includes not only inherited bleeding disorders but also HIV and hepatitis C.
Stay up-to-date on the research programs we fund by subscribing to our newsletter.